S
epsis is a major challenge in medicine. Massive resources have been invested in developing and evaluating potential therapies, and considerable effort has been undertaken to understand the systemic inflammation and multiple-system organ failure characteristics of severe sepsis (1, 2) . Yet, information on the incidence, cost, and outcome of sepsis remains scarce and incomplete. In 1990, the Centers for Disease Control (CDC) estimated that there were 450,000 cases of sepsis per year in the United States, with Ͼ100,000 deaths (3). The CDC warned that the incidence was increasing, citing the aging of the U.S. population and the increased prevalence of human immunodeficiency virus (HIV) infection as contributing factors. However, the CDC study counted cases of septicemia, not severe sepsis, which often occurs in patients without positive blood cultures (4 -6) . Furthermore, this study was based on data from the National Hospital Discharge Survey that are Ͼ10 yrs old, provide no information on patient management, and represent only 1% of all hospital discharges.
In 1992, the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) Consensus Conference arrived at the current definition of sepsis as a systemic inflammatory syndrome in response to infection which, when associated with acute organ dysfunction such as acute renal failure, is said to be severe (7) . These criteria have been adopted widely both in clinical practice and in research. However, there have only been two epidemiologic studies in the United States that used these criteria. One was a single-center study (8) , and the other included only eight academic medical centers (9) . Neither study included children or provided information on population incidence or costs of care. Therefore, we conducted a study of a large, nationally representative sample to determine estimates of the incidence, associated costs, and outcome of severe sepsis in the United States.
METHODS
Data Sources. We constructed a patient database for calendar year 1995 from seven state hospital discharge databases-Florida (10), Maryland (11) , Massachusetts (12), New Jersey (13) , New York (14) , Virginia (15), and Washington (16) . We selected these states based on their geographic representation, data quality and availability, and inclusion of centers in which we could assess the validity of our selection criteria for severe sepsis. For each case, we extracted the following: demographic characteristics; International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for principal discharge diagnosis, Յ14 secondary discharge diagnoses and 15 procedures; hospital discharge status; and selected charge items, listed by both units consumed and dollars charged using the major Health Care Financing Administration (HCFA) UB-92 code categories.
We obtained national and state population data from the U.S. Census (17) . The sevenstate population in 1995 was 63,497,167, or 25% of the U.S. population. Because the U.S. Census does not report separately the number of infants Ͻ1 yr of age, we also obtained the National Center for Health Statistics 1995 natality report (18) . We determined hospital characteristics from the 1995 HCFA Provider Specific File (19) and the American Hospital Association (AHA) Guide to the Health Care Field (20) .
Case Selection and Definitions. To identify cases with severe sepsis, we selected all acute care hospitalizations with ICD-9-CM codes for both a bacterial or fungal infectious process (Appendix 1) and a diagnosis of acute organ dysfunction (Appendix 2). Classifying acute organ dysfunction is controversial with debate over the choice of measurements and the number of systems to measure. We constructed our system by selecting ICD-9-CM codes suggestive of new onset dysfunction within the six organ systems proposed by Marshall et al. (21) and used by Sands et al (9) . We excluded gastrointestinal failure (other than hepatic failure) because it is difficult to define (21, 22) .
We organized patient data under the following categories: demographic; infectious etiology; presence of underlying comorbidity, as determined by a Charlson-Deyo score Ͼ0 (23); resource use, which included intensive care unit (ICU) use and length of stay (LOS), hospital LOS, and total hospital costs; and hospital mortality. We estimated costs by multiplying reported charges by the hospitalspecific cost-to-charge ratios derived from the HCFA Provider Specific File (19) . We defined cases as surgical if they had a major surgical procedure other than tracheostomy.
Comparison of ICD-9-CM Selection Criteria to Standard Clinical and Physiologic Criteria for the Definition of Severe Sepsis. Sands et al. (9) prospectively identified a stratified random sample of patients with severe sepsis at eight academic medical centers during 1993 and 1994 using the ACCP/SCCM Consensus clinical and physiologic criteria (7) . Our study included 1995 data from five of the eight hospitals. Although Sands et al. (9) did not report individual hospital data by hospital name, we were able to compare aggregate data regarding hospital incidence rates and several patient characteristics to determine the extent to which our ICD-9-CM-based selection criteria identified a similar cohort.
Statistical Analyses. We compared continuous data by the Mann-Whitney U test and categorical data by chi-square or Fisher's exact test as appropriate. We assessed risk factors for hospital mortality by multivariate logistic regression with sequential sum of squares. We generated national estimates using the cohort age-and gender-specific rates. We constructed the databases in Foxpro (Microsoft Corp, Redmond, WA) and conducted analyses in Data Desk (Data Description, Ithaca, NY) and SAS (SAS Institute, Cary, NC). were male. Descriptive characteristics are provided in Table 2 . After we adjusted for age and gender, the national incidence rate was 3.0 cases per 1,000 population (2.26 cases per 100 hospital discharges). This produced a national estimate of 751,000 cases per annum, of which 416,700 (55.5%) had underlying comorbidity and 160,700 (21.4%) were surgical. Overall, 383,000 (51.1%) received ICU care. An additional 84,000 (11.1%) received care in a coronary care unit, and 46,000 (6.2%) were ventilated in an intermediate care unit but never received ICU care.
RESULTS

Comparison of Study
The number of cases and incidence rates by age are shown in Figure 1 . The incidence was high in infants (5.3/1,000 aged Ͻ1 yr), decreased quickly in older children (0.2/1,000 aged 5-14 yrs), increased slowly through most of adulthood (5.3/1,000 aged 60 -64 yrs), and increased sharply in the elderly (26.2/1,000 aged Ն85 yrs). The number of cases also increased with age, although the peak was earlier, such that more than half of patients were Ն65 yrs (437,400, 58.3%) and more than one third were Ն5 yrs (274,000, 36.6%). There was also a "bump" in the number of young adults attributable to patients with HIV-related conditions (n ϭ 47,200, average age 38.5 yrs).
Excluding patients with HIV disease, the overall incidence rate for women was similar to that of men (2.87 vs. 2.83 cases per 1,000 population). However, the agespecific incidence rate was lower in women than in men such that, from age 30 onward, women had a rate similar to that of men 5 yrs younger (Fig. 2) . Women were more likely to have genitourinary infections (11.8 vs. 6.3%, p Ͻ .0001) and less likely to have respiratory infections (39.9 vs. 48.1%, p Ͻ .0001) but otherwise had a similar distribution of sites of infection.
Mortality. The overall hospital mortality rate was 28.6%, which represents 215,000 deaths nationally. Mortality rates were higher for patients with preexisting disease, medical conditions, ICU care, and more organ failure (Table 2) . Mortality increased with age from 10% in children to 38.4% in those Ն85 yrs (Fig. 3) . This trend was most obvious in those without underlying comorbidity. For patients with underlying comorbidity, mortality was much higher and changed little throughout most of adulthood.
There was no gender difference in mortality in children, but the mortality rate for men was slightly higher than for women (29.3 vs. 27 .9%, p Ͻ .0001). The widest difference (20.9 vs. 13.9%, p Ͻ .0001) occurred in those 25-30 yrs of age, but the effect was observed throughout adulthood. Excluding HIV cases, mortality rates for women aged Ն30 yrs, like the incidence rates, were similar to that of men 5 yrs younger (Fig. 2) . In multivariate regression, these differences were explained by differences in age, underlying comorbidity, and site of infection. In other words, although the chances of developing sepsis differed for men and women by age, the likelihood of dying from sepsis was the same for men and women after adjusting for age, underlying comorbidity, and site of infection.
Hospital Average and total costs by age are shown in Figure 4 . Adult costs were generally stable around $21,000 -25,000, except in the oldest patients ($14,600 for those aged Ն85 yrs). Infants were the most expensive, with an average cost of $54,300, whereas the average cost for patients aged 1-19 yrs was $28,000. ICU admission rates were generally high The total national hospital cost associated with the care of patients who incurred severe sepsis was $16.7 billion. The costs of care for patients aged Ͻ1 yr and 1-19 yrs were $1.1 billion and $622 million, representing 6.6% and 3.7% of the total costs. The costs of care for patients aged Ն65 and Ն75 yrs were $8.7 billion and $5.1 billion, representing 52.3% and 30.8% of the total costs.
Comparison of Teaching to Nonteaching Hospitals. There were 847 hospitals in our data set, of which 84 (9.9%) were teaching institutions. About one fourth of all cases were managed at these teaching hospitals (Table 3 ). Patients at teaching hospitals were younger, more likely to have HIV disease, and less likely to have chronic obstructive pulmonary disease but otherwise had similar comorbidity, ICU use, and mortality. Both costs and LOS were considerably higher at teaching hospitals. Higher costs and longer LOS also were incurred in larger hospitals when we stratified hospitals by the number of beds (data not shown).
Population-Based Projections of the Future National Occurrence of Sepsis.
Assuming only the U.S. Census-projected changes in the population, we estimated the number of cases to increase steadily at 1.5% per annum, yielding 934,000 and 1,110,000 cases by the years 2010 and 2020. This increase is faster than the anticipated population growth and is attributable to the high incidence of sepsis in older patients and the disproportionate growth of the elderly in the U.S. population.
DISCUSSION
We found that severe sepsis is very common, consumes considerable healthcare resources, and is associated with a high mortality rate. The 215,000 deaths we estimated were 9.3% of all deaths in the United States in 1995 and equaled the number of deaths after acute myocardial infarction (24) . Although many of the deaths after sepsis may not be caused by sepsis, the magnitude of our national estimates underscores the importance of sepsis as a major health problem.
Our overall hospital mortality rate of almost 30% was typical of most prior sepsis studies, but the rate was much lower in children and previously healthy adults. Pediatric and adult sepsis populations have not been studied together before, but a recent study of pneumococcal bacteremia also demonstrated wide variation in mortality from 3.2% in children to 43% in the elderly (25) . Such variation raises the possibilities that the attribut- Figure 1 . National age-specific number and incidence of cases of severe sepsis. National estimates are generated from the seven-state cohort using state and national age-and gender-specific population estimates from the National Center for Health Statistics and the U.S. Census. pop, population.
Figure 2. National age-specific incidence and mortality rates for all cases of severe sepsis by gender, excluding those with HIV disease. National estimates are generated from the seven-state cohort using state and national age-specific population estimates from the National Center for Health Statistics and the U.S. Census. The incidence among women was equivalent to that of men 5 yrs younger. A similar age-based difference was seen in mortality but, in multivariate regression, this difference was explained by underlying comorbidity and site of infection. pop, population. able mortality of sepsis may be much less than the commonly observed 30% and that the mechanism by which sepsis causes death is highly dependent on individual patient factors, many of which may not be reversible by single antisepsis agents. This potential for an attributable mortality much lower than 30% supports the argument that many recent trials of antisepsis agents were underpowered, designed only to find unrealistically large effect sizes (26) .
Clinical trials of antisepsis agents often exclude the very elderly, patients with HIV disease, and patients with malignancy. This is because these patients are believed to be at higher risk of death, as confirmed by our data, and less likely to respond to treatment. The conventional wisdom also may have been that such patients are rare. However, we found that these patients are a large proportion of the sepsis population, and their exclusion will compromise the external validity, or representativeness, of these trials. Because new antisepsis therapies may well be expensive to use (27) , a full understanding of their effectiveness and costeffectiveness in different patient populations is essential.
Beyond the implications for clinical trials, our observation that sepsis is a disease of the elderly also mandates consideration of the appropriateness of care, including determination of patient preferences. Our data suggest that there are already differences in the aggressiveness of treatment in this group, with lower length of stay, ICU use, and hospital costs in those aged Ͼ85 yrs. Yet, aggressive care is not futile in the elderly, and the majority survive to hospital discharge. Unfortunately, there are limited data on the subsequent survival (28) or quality of life (29) after sepsis, especially in the elderly. Such information will be crucial in determining optimal healthcare policy as the U.S. population ages and the number of cases of sepsis increases. There also may be other important trends over time. The large proportion of cases related to HIV may change over time. There is hope that the incidence of HIV infection will continue to decrease, but, with new therapies prolonging survival, prevalence will likely increase. Forecasting the consequences for severe sepsis will be difficult, and we recommend continued follow-up.
Several recent studies have suggested that gender, perhaps through differences in sex hormones (30 -32) , may be an important risk factor for adverse outcome in infection and sepsis. However, some studies found that women fared better (30, 31) whereas others found the opposite (32) . We found that women did have lower age-adjusted severe sepsis rates, mainly attributable to fewer episodes of respiratory origin. We do not know, however, whether this represents a difference in the distribution of risk factors, such as chronic obstructive pulmonary disease, or a difference in access to care. We also found that mortality was lower in women Figure 3 . National age-specific mortality rates for all cases of severe sepsis and for those with and without underlying comorbidity. Comorbidity is defined as a Charlson-Deyo score (23) Ͼ0. National estimates are generated from the seven-state cohort using state and national age-and gender-specific population estimates from the National Center for Health Statistics and the U.S. Census. Error bars represent 95% confidence intervals. Figure 4 . National age-specific average and total hospital costs for severe sepsis. Costs are calculated by multiplying total hospital charges by the hospital-specific cost-to-charge ratio derived from the Health Care Financing Administration Provider Specific File (19) . All costs are expressed as 1995 U.S. dollars. National estimates are generated from the seven-state cohort using state and national age-and gender-specific population estimates from the National Center for Health Statistics and the U.S. Census.
but that this was explained by differences in age, comorbidity, and site of infection. The gender differences we observed were consistent throughout adulthood, with no obvious link to menopause, suggesting that the differences are not solely mediated through sex hormones. Thus, we recommend that future research on gender differences in sepsis focus on understanding the processes that lead to the site and type of infection and on understanding whether there are systematic differences in healthcare access and delivery.
There is limited information on the hospital costs and resource use associated with the care of septic patients. Chalfin et al. (33) analyzed 1,405 patients at a teaching hospital and estimated mean total charges of $38,304 in survivors and $49,182 in nonsurvivors. When we adjust for inflation and use an average cost-tocharge ratio, these estimates are consistent with our findings for costs at teaching hospitals. Costs of care appear lower at nonteaching hospitals, attributable presumably to differences in case-mix, differences in care, such as the costs of teaching, or both. Perhaps contrary to clinical intuition, we found that many patients with sepsis did not receive ICU care. This observation was also made by others (8, 9) . Whether such patients would have benefited from ICU care is unclear, and it is possible that the ACCP/ SCCM definition for severe sepsis, intended for ICU patients, selects different types of patients on the hospital floor.
The major limitations of our study relate to the use of administrative data to define sepsis. We selected states from the West, Northeast, Midatlantic, and Southeast regions. Although these regions represent the most heavily populated areas of the United States, we did not have representation from the Midwest or Southwest. Unfortunately, there are no statewide hospital databases from these regions with the appropriate level of detail and quality for this study. However, when generating national estimates, we adjusted for differences in population distribution between the seven-state cohort and the entire country, and we do not anticipate that additional data from the Midwest or Southwest would have altered any of our national estimates substantially. We used data from 1995, the last full year for which data were available from all seven states when we began the study. There have been no significant changes in the management of sepsis since that time, and therefore, other than the 1.5% annual increase in incidence with the aging of the population, we believe our estimates reflect current practice.
We could only identify sepsis by using ICD-9-CM codes, rather than clinical and physiologic measurements. The data set was not designed primarily for research and consequently did not necessarily have the same level of data auditing and quality that might be expected in a prospective study. Although our definition combined infection with organ dysfunction within the same admission, the time overlap was not as tight as in clinical trials, which usually specify an overlap of infection and organ failure within a time window of 12-72 hrs, depending on the study. Our definition of severe sepsis also could be considered more inclusive than others (e.g., a patient with bacterial pneumonia would be considered to have severe sepsis if mechanical ventilation was required). Finally, both the hospital costs and mortality rates are all-cause estimates and not the attributable costs or mortality rates of sepsis. Thus, preventing sepsis altogether would only diminish, and not extinguish, these costs and deaths. At the same time, our estimates do not include costs or mortality rates after hospital discharge. There is evidence that hospital survivors of severe sepsis remain at considerably increased risk of death compared with nonseptic controls (28) .
Despite these limitations, our approach captured patients similar to those identified using more rigorous prospective screening criteria. In addition to the close comparison with Sands et al. (9) , our findings with regard to site of infection, ICU use, and hospital mortality are also very similar to the other U.S. study, by Rangel-Frausto et al. (8) We believe the comparison of our ICD-9-CM coding scheme to the prospective criteria was a strength of this study. However, the validity of our included children and if detailed chart review had been possible.
In conclusion, we found that severe sepsis is a common, frequently fatal, and expensive condition. It is especially common in the elderly and is likely to increase substantially in the coming years as the U.S. population ages. Although we applaud the continued search for effective antisepsis drugs, we also encourage attention to other aspects of care. In particular, we believe that this study highlights a variety of epidemiologic and health services research issues that remain poorly understood, including optimal delivery of care for vulnerable and elderly populations.
